Aims-To investigate the feasibility of using fixed cells with the polymerase chain reaction (PCR) in situ hybridisation and to investigate possible reasons for reaction failure. Methods-Fixed SiHa and CaSki cells were used in an experimental model of PCR in situ hybridisation for the detection of low and intermediate copy number viral infection in fixed cells.
Abstract
Aims-To investigate the feasibility of using fixed cells with the polymerase chain reaction (PCR) in situ hybridisation and to investigate possible reasons for reaction failure. Methods-Fixed SiHa and CaSki cells were used in an experimental model of PCR in situ hybridisation for the detection of low and intermediate copy number viral infection in fixed cells. Results -PCR in situ hybridisation was able to detect one to two copies of human papillomavirus (HPV) 16 in SiHa cells, using small fragment amplicons (120 base pairs), confirming the high detection sensitivity and flexibility of the technique. Problems were encountered with localisation of PCR amplified product in CaSki cells (200-300 copies of HPV 16 per cell) owing to diffusion of product post amplification. Overall, 40% of reactions were successful, which confirms the current unreliability of the technique.
Within cell preparations, about 50% of cells contained amplified product. Conclusion-PCR in situ hybridisation represents the marriage of two revolutionary molecular pathological techniques. However, it is currently unreliable, with reaction failure common. Standardised, dedicated equipment is urgently required if the technique is to achieve universal acceptance. In the future, the technique may be used to detect chromosomal translocations in human tumours and to study cellular gene expression. (7 Clin Pathol 1994; 47:933-938) The polymerase chain reaction (PCR) permits the selective in vitro amplification of a particular region of nucleic acid by mimicking the phenomena of in vivo DNA replication.' PCR has been extensively used to amplify specific DNA sequences for use in the molecular analysis of many diseases, for which formalin fixed, paraffin wax embedded tissue has been used. However, one limitation for the histopathologist was that it was impossible to localise amplified DNA sequences in cells or tissue sections. Recently, several studies have described a new technique which combines PCR with in situ hybridisation, permitting the localisation of specific amplified DNA signals within isolated cells and tissue sections. This technique has been variously known as in situ PCR or PCR in situ hybridisation.
In situ PCR refers to use of a biotin or digoxigenin labelled nucleotide directly in the PCR mix and subsequent detection of the labelled amplified product using standard in situ detection protocols. PCR in situ hybridisation occurs when PCR amplification of a tissue section or cell suspension is carried out, followed by application of a biotin or digoxigenin labelled probe to the amplified product and detection of the hybrid by standard in situ detection protocols. The The cells were removed from the flask by digestion with trypsin (0-2% trypsin in Hank's balanced salt solution), and collected in a falcon tube. The cells were then pelleted by centrifugation for five minutes at 3000 rpm. Washing in phosphate buffered saline (PBS) was then performed and the cell pellet was resuspended in neutral buffered formalin, mixed well, and stored for the required fixation time. (Fixation time of 24-48 hours was usually found to be adequate and provided good penetration of the cell pellet.) After fixation the cells were centrifuged at 3000 rpm for five minutes and then resuspended in "demiwater" (50% neutral buffered formaldehyde and 50% sterile distilled water) and transferred to a 10-15 ml glass tube. The cells were washed with water and graded alcohols to 100% alcohol. The cell pellet was suspended in xylene, mixed well (end over rotation), and centrifuged at 3000 rpm for five minutes.
Xylene was discarded carefully. Paraffin wax at 65°C was carefully added and the cells resuspended overnight at 65°C. The glass tube containing the cells was then placed at -20°C for three to four hours, removed, and the glass broken with a hammer and the cell pellet retrieved. The cell pellet was reembedded in a tissue cassette, applied to a microtome support, and 5 pm sections cut.
Glass single well and multi-well slides (PH106, PHOO5, Hendley Essex) were coated with 2% aminopropyltriethoxysilane, as described before for hybridisation.6
Sections (5 pm) were cut on to the "welled" slides and placed on a hot plate for 24 to 48 hours to achieve maximum section adhesion. Section dewaxing was carried out by immersing the slides in xylene at 37°C, for 30 minutes, followed by xylene at room temperature for 10 minutes, and absolute alcohol at room temperature for a further 10 minutes. The slides were transferred to fresh absolute alcohol and rehydrated through a graded alcohol series to water over a 10 minute period. The prepared sections were immersed in 0-02M HC1 for 10 minutes, washed twice in PBS for five minutes each, and treated with 0-01% Triton X-100 in PBS for three minutes. After this, the sections were washed twice in PBS for five minutes each and then incubated in prewarmed proteinase K buffer (50 mM TRIS-HCI, pH 7-6, 5 mM EDTA) at 37°C for 10 minutes and then treated with proteinase K (0.1-0.5 mg/ml) at 37°C for 10 to 20 minutes. The slides were washed in two changes of PBS containing 2 mg/ml of glycine for five minutes each, followed by immersion in aqueous 20% acetic acid at 4°C for 15 seconds. The sections were then washed in two changes of PBS for 10 minutes each and postfixed in 4% paraformaldehyde in PBS for five minutes. Washing in PBS for five minutes was then performed, and the sections were dehydrated through graded alcohols.
For amplification of paraffin wax embedded cell lines, the slide containing the fixed cell suspension was placed in an aluminium foil boat, trimmed to slightly larger proportions than the slide. PCR solution (20 pl) consisting of PCR buffer (50 mM KC1, 10 mM TRIS-HCI (pH 8 3) at room temperature, 4-5 mM MgClI, 0-01% gelatin) and 200 mM each of dNTP and 5 ,uM primers were placed on top of the cell suspension. The well was covered with a pre-cut piece of Gel Bond (FMC Bioproducts), hydrophobic side down. The slide (in the aluminium foil boat) was placed on the heating block of the thermal cycler and the temperature allowed to increase to 80°C. Once the temperature had reached 80°C, a corner of the gel bond was lifted and 25 jul Taq DNA polymerase (2-5 units per 12-5 ,ul final concentration) were added to the PCR mix contained on the slide. The coverslip (gel bond) was then replaced and the margins sealed with nail polish. Preheated mineral oil (1-2 ml) (80°C) was placed on top of the slide to ensure optimal thermal kinetics. The following PCR protocol was applied: 94°C for six minutes, 40 cycles of 55°C for two minutes, and 94°C for one minute.
The temperatures given refer to the temperatures of the glass slide. This was checked using a thermocouple device. It is important that the initial denaturation temperature and cycling temperatures are achieved on the glass slide. After amplification the slide was dipped in chloroform to remove mineral oil and the gel bond coverslip carefully removed. Gel Bond, hydrophobic side towards the cell suspension, allows the PCR reagent mix to remain on the tissue in the well.
After amplification the slides were dipped carefully in 100% alcohol and dehydrated. Post fixation in 2% paraformaldehyde to maintain localisation of PCR product was also carried out. 
I
Biotinylated and digoxigenin labelled genomic HPV 16 probe contained in pBR322 (a gift from Dr Zur Hausen) was prepared using the nick translation labelling technique.
The HPV 16 probe (75 p1) (200 ng/ml) in hybridisation buffer (50% dextran sulphate, 2 x SSC, 0-2% dried milk powder, 50% formamide) was applied to the centre of the well of the PH1 06, C A Hendley glass slide (SSC = sodium chloride and sodium citrate). For multiwell slides (PHOO5, C A Hendley), 8-10 1l of probe was applied to the centre of the well. Gel bond films were cut to coverslip size and placed hydrophobic side down, over each section. The gel bond was sealed in place with nail varnish.
Slides were placed onto a preheated baking tray and incubated at 90-95°C for 10 minutes. Finally, the slides were transferred to a humidified box and incubated at 37-420C overnight or at 42°C for two hours.
For posthybridisation washes, the gel bond coverslips were removed with a scalpel blade and the slides washed in SSC with agitation according to the following protocol: The following solutions were required for hybridisation detection protocols:
Buffer 1 (0IM TRIS-HCI (pH 7.5), 01M NaCl, 2 mM MgCl,, and 0'05% Triton-X-100).
Buffer 2 (0O1M TRIS-HCI (pH 9 5), 01M NaCl, 50 mM MgCl2). Development reagent (NBT/BCIP)-alkaline phosphate detection system. A fresh solution was made just before use and kept in the dark. This consisted of buffer 2 (3 75 ml), nitroblue tetrazolium (NBT) (16-5 pl), bromochloroindoyl phosphate (BCIP) (12-5 ,ul) . TBS (TRIS-buffered saline) (50 mM TRIS-HC1, 100 mM NaCl, pH 7 2). TBT (blocking reagent) for the detection of digoxigenin labelled probes (50 mM TRIS-HC1, 100 mM NaCl (pH 7 2), 3% (w/v) bovine serum albumin (BSA) and 0 5% Triton X-100 (v/v)).
For the detection of biotinylated probes,7 the slides from the posthybridisation wash steps were transferred into buffer 1 containing 5% (w/v) BSA and incubated at room temperature for a minimum of 30 minutes. Excess buffer was wiped from the slides and the slides transferred to a slide incubation tray. A few drops of buffer 1 containing Avidin DN (Vector) at a concentration of 10 ,ul/ml were added and the slides incubated at room temperature for 10 minutes. The slides were washed with agitation in two changes of buffer 1 for 10 minutes each. The slides were then returned to the incubation tray and a few drops of buffer 1 containing biotinylated alkaline phosphatase (Vector) at a concentration of 10 ,l/mi were added to each section.
Incubation at room temperature for 10 minutes was carried out. The slides were washed with agitation twice in buffer 1 6) . This was due to leakage of PCR amplified product from the site of amplification. Again, when Taq DNA polymerase was omitted from the amplifying solution, the normal copy number of HPV per CaSki cells was identifiable (fig 7) . Cellular morphology preservation, however, was compromised.
In all cases fi globin gene was amplifiable from fixed cells using solution phase PCR. Again, HPV 16 primers yielded amplicons of appropriate size when used in solution phase PCR, but HPV 6, 11, 18, and 33 primers did not give amplification either with solution phase or PCR in situ hybridisation.
Discussion
In this study we examined the newly developed technique of PCR in situ hybridisation using fixed SiHa and CaSki cell lines as an experimental model for the detection of low and intermediate copy numbers of viral pathogens in fixed cells. We do not purport to have examined human structural genes. We were able successfully to amplify one to two copies of HPV 16 in fixed SiHa cells, which are not normally detectable with standard non-isotopic in situ hybridisation, except for complicated five-step sandwich techniques,9 as mentioned earlier. Discrete and diffuse signals were seen within the nucleoplasm of the fixed SiHa cells (figs 1, 2A, 2B, and 3) . Fixation of cells for up to 24 hours appeared to yield material suitable for use with PCR in situ hybridisation. The results confirm the sensitivity of the technique for the detection of low copy number viral infection in infected cells. Fixed CaSki cells were also amplifiable after 12 to 24 hours of fixation. Problems with localisation of signal were commonly seen when using CaSki cells (fig 6) . The reason for this is that the starting copy number of HPV in CaSki cells is much higher than in SiHa cells (200-300 copies compared with one to two copies). Such diffusion of product makes cytological and histological interpretation difficult. To overcome such diffusion problems, we advocate the use of paraformaldehyde and 100% alcohol dehydration after amplification. We have also clearly shown in this study that small amplicon PCR in situ hybridisation (120 base pairs) can be carried out successfully on fixed tissues using a single primer pair and the "hot start" PCR modification. In both experimental systems not all cells contained amplifiable product. This was primarily due to leakage of amplified product from truncated cells which have been cut by the microtome blade during sectioning of cells for the reaction-very much like a leaky bucket.
The success rate of the reaction (40%) was low, with failure and patchy amplification common. This is a poor success rate when compared with conventional in situ hybridisation. The choice of reporter molecule (biotin/digoxigenin) did not seem to affect the success rate of the reaction with equally sensitive results obtained with both reporter molecules.
Many centres have experienced consistent failure using PCR in situ hybridisation or in situ PCR. The following points should therefore be considered: 1 The cytoskeleton of the cell should be made rigid before PCR in situ hybridisation, to prevent cytoskeletal collapse during amplification. Cells or tissues should be fixed with formaldehyde. However It is difficult to minimise such sequestration. However, Yap and McGee"4 have reported that 0'1 to 1 0% BSA is needed to achieve successful amplification of glass slide mounted tissue in "slide PCR" (a technique related to PCR in situ hybridisation, where amplification takes place on microscope slides and the amplified product is then analysed by standard electrophoresis)-BSA in this case possibly blocks sequestration of reagents during the reaction. In PCR in situ hybridisation, lower concentrations of Taq and primers can be used if slides are pretreated with 1% BSA (unpublished observation, data not shown). 5 The success of in situ PCR depends on the amplified DNA product remaining localised. It is not clear how amplified DNA does not diffuse away from the site of amplification, but in our experience products of the order of 100 base pairs tend to diffuse quite readily. Postfixing the amplified product with 2% paraformaldehyde improves localisation. In the future immunofixation with lupus serum (containing anti-DNA antibodies) may be of use to maintain localisation of product. 6 Patchy amplification is also encountered, with amplification occurring preferentially in some parts of the tissue section or cell suspension. This may be due to inadequate digestion during pretreatment, lingering DNA crosslinking phenomena (because of prior fixation of cells), and variations in the volume of PCR reactants over the slide during the reaction. 7 The thermal profile of the reaction can differ at several sites on the slide/cell suspension and indeed varies from top to bottom of the slide and between the slide and the thermal block of the PCR machine (fig 8) . This is the overwhelming reason why it is necessary to use a thermocouple to optimise heat transfer kinetics during amplification.
Currently, PCR in situ hybridisation or in situ PCR has little to offer over conventional in situ hybridisation. In the future, the technique may be useful for the detection of low copy number viral infections, in the study of the cellular expression of cellular oncogenes, growth factors, etc., and in the diagnosis of chromosomal translocations in certain tumour types (lymphomas, primitive neuroectodermal tumours, and Ewing's sarcoma). But the technique is still not reliable and PCR plus NISH techniques are inherently complex and expensive. Standardisation of instrumentation and simplification of the technique are required in the near future, if the technique is to receive universal acceptance.
